Toni Hofhine @tonihofhine

Let’s explore how expanding vital signs monitoring with ATCOR’s digital vascular biomarkers can improve performance outcomes and enhance personalized medicine treatments. We should talk at #NAA2023! $CDX Contact us here tinyurl.com/bdzzv85p

Join Alberto Avolio, Ph.D., on June 16 for his presentation on “Empowering Patients in the Transition to the Digital Revolution” at the 2023 NAA Conference scheduled in Iowa City, Iowa. $CDX #NAA2023 Click here to request a presentation overview: tinyurl.com/bdzzv85p

Exciting news! CardieX Limited has been selected for @MedTechAwards 2023 Accelerator Cohort, recognizing our commitment to improving cardiovascular health. $CDX #MedTechInnovator #CardiovascularHealth #Innovation #HealthcareTechnology Full story here: tinyurl.com/yeaenyzr

Let’s explore how expanding vital signs monitoring with ATCOR’s digital vascular biomarkers can improve performance outcomes and enhance personalized medicine treatments. We should talk at #VAM23! $CDX Contact us here tinyurl.com/bdzzv85p

CardieX is making waves as a top ASX medtech with its recent FDA breakthrough! The @australian newspaper showcased our cutting-edge innovations in the medical technology sector. Full story here: tinyurl.com/2dzsewzd #CardieX #MedTech #ASX #Innovation #FDA #Breakthrough $CDX

Cardiex CSO Catherine Liao joined renowned cardiologist @DrRossWalker on his Healthy Living program to discuss the CONNEQT Pulse, the world-first vascular biometric monitor. Listen to the full interview here: tinyurl.com/rer7ktpf  #CardieX #HealthyLiving $CDX

Connect with us to explore how expanding vital signs monitoring with ATCOR’s digital vascular biomarkers can improve performance outcomes and enhance personalized medicine treatments. Let’s talk at #ASCO23! $CDX Contact us here tinyurl.com/bdzzv85p

Connect with us to explore how ATCOR digital vascular biomarkers improve performance outcomes and personalized exercise and therapy programs. Stop by our ATCOR booth #525 at ACSM next week! $CDX #ACSM23 Contact us here tinyurl.com/bdzzv85p

ATCOR announced our new single-center heart health retrospective study of 2,000 patients with elevated blood pressure to identify associated care outcomes resulting from routine monitoring of central aortic and peripheral blood pressure. $CDX Full story: tinyurl.com/572j2awu

On #ClinicalTrialsDay, we honor the researchers, participants, and healthcare professionals who drive medical advancements through their dedication to clinical trials. Learn more about ATCOR’s commitment to clinical trials here: tinyurl.com/5xdxtenk $CDX

Mass Device noted that the CONNEQT Pulse received FDA 510(k) clearance and highlighted that “its vascular biometric reporting enables a precise and personalized view of vascular health.” Full story here: tinyurl.com/mtfkzwcs $CDX #cardiovascularhealth #medtech #innovation

Gadgets & Wearables highlighted that the CONNEQT Pulse has been granted FDA 510(k) clearance. Learn about the Pulse’s impressive range of abilities by reading the full story here: tinyurl.com/p2tewwen $CDX #innovation #digitalhealth #telehealth #medtech

Monitoring vital signs matters and positively impacts patient safety across decentralized trials and healthcare. The CONNEQT Pulse grows our family of digital biomarker medical devices to revolutionize patient access, anywhere. We are thrilled with our FDA 510(k) clearance!

CONNEQT Health @conneqthealth

a year ago

Monitoring vital signs matters and positively impacts patient safety across decentralized trials and healthcare. The CONNEQT Pulse grows our family of digital biomarker medical devices to revolutionize patient access, anywhere. We are thrilled with our FDA 510(k) clearance!

0 7 28 1K 1

Download Image

@mHealthIntel highlighted that CardieX and the CONNEQT Pulse have reached the final stage of the RADx Tech for Maternal Health Challenge. $CDX Read the full story here: tinyurl.com/ydpnjyxw

You don’t want to miss it! We are excited to announce that Alberto Avolio, PhD will be presenting at the June 2023 NAA Conference in Iowa. Register Today! naartery.org/2023naaconfere….

North American Artery Society @NAASociety

a year ago

You don’t want to miss it! We are excited to announce that Alberto Avolio, PhD will be presenting at the June 2023 NAA Conference in Iowa. Register Today! naartery.org/2023naaconfere….

0 3 12 815 0

Download Image

ATCOR is excited and proud to partner and contribute in @_DiMeSociety's new Extending the Verification, Analytical Validation, and Clinical Validation (V3+) Framework project. $CDX

During Colorectal Cancer Awareness Month, we highlight a Toohey et al. study that assessed PWV using the SphygmoCor XCEL to show that low to moderate-intensity training could improve measures of arterial stiffness in cancer survivors. $CDX Full story: tinyurl.com/4fw8fuze

Some good coverage from @Clin_Info_News about how ATCOR and our new partner, Power, are shifting the paradigm on clinical trial diversity. $CDX #clinicaltrials Read more here: tinyurl.com/27f5zf6j

Contact us before 2/28 about special package pricing on our industry-leading medical devices that provide your US clinical research program with our digital vascular biomarker toolbox. tinyurl.com/mr2xmakj $CDX #hearthealth #clinicaltrial #medicaldevices

@AARP featured the Pulse in its list of new at-home medical tests. “There’s an increased opportunity for people to be more in control of their health data,” says CONNEQT’s @markgorelick. “Trend data is what’s really important: Is there a change tinyurl.com/ycke2w2n…